23 results
8-K
EX-99.1
SCYX
Scynexis Inc
10 Nov 21
SCYNEXIS Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:45am
impacted by the COVID-19 pandemic additional time to secure patients for this important trial. SCYNERGIA, which is evaluating oral ibrexafungerp … . The prioritization of hospital resources toward addressing the COVID-19 pandemic has impacted the ability of many institutions to focus on screening and enrolling
8-K
EX-99.1
SCYX
Scynexis Inc
21 Apr 20
SCYNEXIS Announces Positive Top-Line Results from its Second Pivotal
2:36pm
costs of studies and when they might begin or be concluded; the effects that theCOVID-19 pandemic may have on SCYNEXIS, its supply chain and clinical